Andrew C. Jackson's Net Worth
$32.4 Thousand
Who is Andrew C. Jackson?
Andrew C. Jackson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Ra Medical Systems, Inc., Celladon Corp, Brooklyn ImmunoTherapeutics, Inc., and Calidi Biotherapeutics, Inc..
SEC CIK
Andrew C. Jackson's CIK is 0001636738
Past Insider Trading and Trends
2020 was Andrew C. Jackson's most active year for acquiring shares with 6 total transactions. Andrew C. Jackson's most active month to acquire stocks was the month of April. 2019 was Andrew C. Jackson's most active year for disposing of shares, totalling 3 transactions. Andrew C. Jackson's most active month to dispose stocks was the month of October. 2020 saw Andrew C. Jackson paying a total of $11,346.80 for 70,476 shares, this is the most they've acquired in one year. In 2019 Andrew C. Jackson cashed out on 14,280 shares for a total of $27,588.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ra Medical Systems, Inc. (VTAK) Snapshot price: $0.402
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.91% | -1.36K |
$0.30 | -$410.07 | 21.68K |
May 20
| |||
Form 4
| -38.53% | -14.44K |
$2.62 | -$7,032.08 | 23.04K |
Nov 20 - Nov 22
| |||
Form 4
| +0.54% | 200 |
$5.43 | $1,086.30 | 37.48K |
Nov 20
| |||
Form 4
| +1,756.77% | 35.28K |
—
|
—
| 37.28K |
Nov 17
| |||
Form 4
| +24.87% | 10K |
$0.35 | $3,500.00 | 50.2K |
Aug 3
| |||
Form 4
| +33.11% | 10K |
$0.46 | $4,648.00 | 40.2K |
May 22
| |||
Form 4
| +19.84% | 5K |
$0.42 | $2,112.50 | 30.2K |
May 20
| |||
Form 4
| -15.55% | -4.64K |
$0.90 | -$4,181.54 | 25.2K |
Dec 20
| |||
Form 4
| -13.12% | -4.50K |
$1.69 | -$7,613.45 | 29.84K |
Dec 3 - Dec 4
| |||
Form 4
| -13.00% | -5.13K |
$3.08 | -$15,793.72 | 34.35K |
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celladon Corp (EIGR) No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Brooklyn ImmunoTherapeutics, Inc. (ERNA) Snapshot price: $1.73
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Calidi Biotherapeutics, Inc. (CLDI) Snapshot price: $1.17
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||